Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
Kirby Daniel Gordon exercised options for 10,000 Iovance Biotherapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Kirby Daniel Gordon (Chief Commercial Officer) exercised options for 10,000 Iovance Biotherapeutics, Inc. shares, leaving 146,946 shares. Filed May 13, 2026 (Form 4).
- Options exercised
- 10,000 shares
- Holding after
- 146,946 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Option exercise | 10,000 | 149,381 | Direct | |
| May 11, 2026 | Common Stock | Shares withheld for tax | 2,435 | US$3.70 | 146,946 | Direct |
Source
Related
- Iovance Biotherapeutics, Inc.
- Kirby Daniel Gordon
- Iovance Biotherapeutics, Inc. shareholders
- Form 4 · Kirby Daniel Gordon · Aug 12, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026